Liver support system devices and methods thereof

Patent metadata

Field	Value
Publication number	US-11517855-B2
Application number	US-201716328478-A
Country	US
Kind code	B2
Filing date	Sep 5, 2017
Priority date	Sep 6, 2016
Publication date	Dec 6, 2022
Grant date	Dec 6, 2022

Abstract

The present disclosure relates to an artificial, extracorporeal system for supporting the function of the liver of a patient suffering from liver failure, which is characterized in that it comprises a first high-flux or high cut-off hollow fiber membrane dialyzer which is perfused on the lumen side with the patient's blood and wherein a buffered aqueous solution comprising human serum albumin is passed in a continuous flow through the filtrate space of said first dialyzer, a second hollow fiber membrane dialyzer which removes water-soluble substances from the dialysate of said first dialyzer, and a third, integrated hollow fiber membrane dialyzer which is perfused with the retentate of second hemodialyzer and which allows the passage of certain amounts of albumin over the membrane wall into the filtrate space which is populated with adsorbent material. The system can be used for the treatment of acute liver failure and acute-on-chronic liver failure.

First claim

The invention claimed is:

1. A device comprising
(a) a first hollow fiber membrane dialyzer comprising a filtrate side
wherein the first hollow fiber membrane dialyzer comprises a high cut-off membrane having a molecular weight cut-off in water, based on dextran sieving coefficients, of between about 170 kD and about 320 kD and a molecular weight retention onset in water, based on dextran sieving coefficients, of between about 15 kD and about 20 kD,
wherein the first hollow fiber membrane dialyzer is configured for perfusion on the filtrate side of the first hollow fiber membrane dialyzer with a dialysate solution in a direction opposite to blood flow within the first hollow fiber membrane dialyzer, and
wherein the dialysate solution comprises human serum albumin (HSA);

(b) a second hollow fiber membrane dialyzer comprising a filtrate side and a lumen side,
wherein the second hollow fiber membrane dialyzer comprises a hollow fiber membrane,
wherein the second hollow fiber membrane dialyzer is configured for receiving the dialysate solution from the first hollow fiber membrane dialyzer,
wherein the second hollow fiber membrane dialyzer is configured for passing the dialysate solution through the lumen side of the second hollow fiber membrane dialyzer, and
wherein the second hollow fiber membrane dialyzer is configured for perfusion on the filtrate side of the second hollow fiber membrane dialyzer with a buffered aqueous solution in a direction opposite to the passing of the dialysate solution through the lumen side of the second hollow fiber membrane dialyzer; and

(c) a third hollow fiber membrane dialyzer comprising a filtrate side, a lumen side, and a filtrate space,
wherein the third hollow fiber membrane dialyzer comprises a hollow fiber membrane,
wherein the filtrate side of the third hollow fiber membrane dialyzer is configured to be in fluid connection only with the lumen side of the third hollow fiber membrane dialyzer,
wherein the lumen side of the third hollow fiber membrane dialyzer is configured for receiving the dialysate solution from the second hollow fiber membrane dialyzer, and
wherein the filtrate space of the third hollow fiber membrane dialyzer comprises at least one adsorbent.

2. A device according to claim 1 , wherein the hollow fiber membrane of the second hollow fiber membrane dialyzer is a low-flux membrane having a molecular weight cut-off in water, based on dextran sieving coefficients, of between about 10 kD and about 20 kD and a molecular weight retention onset in water, based on dextran sieving coefficients, of between about 2 kD and about 4 kD.

3. A device according to claim 1 , wherein
i) the high cut-off membrane of the first hollow fiber membrane dialyzer comprises A) at least one hydrophobic polymer selected from the group consisting of polyarylethersulfone (PAES), polypropylene (PP), polysulfone (PSU), polycarbonate (PC), polyacrylonitrile (PAN), polyamide (PA), polytetrafluorethylene (PTFE), or combinations thereof and B) at least one hydrophilic polymer selected from the group consisting of polyvinylpyrrolidone (PVP), polyethyleneglycol (PEG), polyvinylalcohol (PVA), and a copolymer of polypropyleneoxide and polyethyleneoxide (PPO-PEO); or
ii) the hollow fiber membrane of the second hollow fiber membrane dialyzer comprises A) at least one hydrophobic polymer selected from the group consisting of polyarylethersulfone (PAES), polypropylene (PP), polysulfone (PSU), polycarbonate (PC), polyacrylonitrile (PAN), polyamide (PA), polytetrafluorethylene (PTFE), or combinations thereof and B) at least one hydrophilic polymer selected from the group consisting of polyvinylpyrrolidone (PVP), polyethyleneglycol (PEG), polyvinylalcohol (PVA), and a copolymer of polypropyleneoxide and polyethyleneoxide (PPO-PEO); or
iii) the hollow fiber membrane of the third hollow fiber membrane dialyzer comprises A) at least one hydrophobic polymer selected from the group consisting of polyarylethersulfone (PAES), polypropylene (PP), polysulfone (PSU), polycarbonate (PC), polyacrylonitrile (PAN), polyamide (PA), polytetrafluorethylene (PTFE), or combinations thereof and B) at least one hydrophilic polymer selected from the group consisting of polyvinylpyrrolidone (PVP), polyethyleneglycol (PEG), polyvinylalcohol (PVA), and a copolymer of polypropyleneoxide and polyethyleneoxide (PPO-PEO); or
iv) any combination of i), ii), and iii).

4. A device according to claim 1 , wherein the hollow fiber membrane of the third hollow fiber membrane dialyzer allows passage of substances having a molecular weight of up to about 45 kD with a sieving coefficient measured in whole blood of between about 0.1 and about 1.0.

5. A device according to claim 1 , wherein the third hollow fiber membrane dialyzer is selected adsorbent chosen from the group consisting of activated carbon, carbon nanotubes, hydrophobic silica, styrenic polymers, polydivinylbenzene polymers, styrene-divinylbenzene copolymers, and any combination thereof.

6. A device according to claim 1 , wherein the third hollow fiber membrane dialyzer comprises i) a combination of at least one activated carbon, at least one copolymer of styrene and divinylbenzene without any functional groups, and at least one copolymer of styrene and divinylbenzene carrying trimethylbenzyl ammonium functional groups, or ii) a combination of at least one copolymer of styrene and divinylbenzene without any functional groups, and at least one copolymer of styrene and divinylbenzene carrying trimethylbenzyl ammonium functional groups.

7. A device according to claim 1 , wherein the third hollow fiber membrane dialyzer comprises a fiber packing density in the range of from about 15% to about 50%.

8. A device according to claim 1 , wherein the second hollow fiber membrane dialyzer is configured for removing water-soluble toxins from the dialysate solution received from the first hollow fiber membrane dialyzer.

9. A device according to claim 1 , wherein the adsorbent of the third hollow fiber membrane dialyzer is configured for binding or adsorbing protein-bound toxins from the dialysate solution received from the second hollow fiber membrane dialyzer.

10. A device according to claim 1 , wherein the adsorbent of the third hollow fiber membrane dialyzer is configured for binding or adsorbing hepatic toxins from the dialysate solution received from the second hollow fiber membrane dialyzer.

11. A device comprising
(a) a first hollow fiber membrane dialyzer comprising a filtrate side,
wherein the first hollow fiber membrane dialyzer comprises a high-flux membrane having a molecular weight cut-off in water, based on dextran sieving coefficients, of between about 25 kD and about 65 kD and a molecular weight retention onset in water, based on dextran sieving coefficients, of between about 5 kD and about 10 kD,
wherein the first hollow fiber membrane dialyzer is configured for perfusion on the filtrate side of the first hollow fiber membrane dialyzer with a dialysate solution in a direction opposite to blood flow within the first hollow fiber membrane dialyzer, and
wherein the dialysate solution comprises human serum albumin (HSA);

(b) a second hollow fiber membrane dialyzer comprising a filtrate side and a lumen side,
wherein the second hollow fiber membrane dialyzer comprises a hollow fiber membrane,
wherein the second hollow fiber membrane dialyzer is configured for receiving the dialysate solution from the first hollow fiber membrane dialyzer,
wherein the second hollow fiber membrane dialyzer is configured for passing the dialysate solution through the lumen side of the second hollow fiber membrane dialyzer, and
wherein the second hollow fiber membrane

Assignees

• Gambro Lundia Ab

Inventors

• Flieg Ralf
• Krause Bernd
• Storr Markus

Classifications

• B01D2317/025

  Permeate series · CPC title

• B01D2325/20

  Specific permeability or cut-off range · CPC title

• B01D69/02

  characterised by their properties · CPC title

• B01D2311/2626

  Absorption or adsorption · CPC title

• B01D61/28

  Apparatus therefor · CPC title